Skip to main content
. 2021 Mar 2;10(5):970. doi: 10.3390/jcm10050970

Table 1.

Demographic, clinical and pathological characteristics of the total group of PTC patients and two subgroups according to BMI. Data are presented as the number of observations (percent) or mean ± SD.

Parameters Total Group 1: BMI < 25 kg/m2 (n = 373) Group 2: BMI ≥ 25 kg/m2 (n = 150) p-Value
(n = 523)
Sex: 0.724
Female 456 (87.2) 324 (86.9) 132 (88.0)
Male 67 (12.8) 49 (13.1) 18 (12.0)
Age at diagnosis (years) 49.82 ± 15.67 48.59 ± 16.25 52.86 ± 13.73 0.005 *
Age: 0.127
<55 years 306 (58.5) 226 (60.6) 80 (53.3)
≥55 years 217 (41.5) 147 (39.4) 70 (46.7)
TSH (mU/L) 1.79 ± 1.14 1.45 ± 0.97 2.63 ± 1.08 <0.0001 *
Glucose (mmol/L) 4.86 ± 0.51 4.75 ± 0.49 5.16 ± 0.44 <0.0001 *
Diagnosis of thyroid malignancy: <0.0001 *
Before surgery 317 (60.6) 247 (66.4) 70 (47.0)
After surgery 206 (39.4) 125 (33.6) 79 (53.0)
Type of surgery: <0.0001 *
Radical 381 (72.8) 291 (78.0) 90 (60.0)
Not radical 142 (27.2) 82 (22.0) 60 (40.0)
Reoperation needed: 0.0001 *
No 388 (74.2) 294 (78.8) 94 (62.7)
Yes 135 (25.8) 79 (21.2) 56 (37.3)
pTNM stage: 0.894
I 433 (82.8) 307 (82.3) 126 (84.0)
II 67 (12.8) 50 (13.4) 17 (11.3)
III 15 (2.9) 10 (2.7) 5 (3.3)
IV 8 (1.5) 6 (1.6) 2 (1.3)
Tumor stage: 0.012 *
pT1a 209 (40.0) 136 (36.5) 73 (48.7)
pT1b 238 (45.5) 181 (48.5) 57 (38.0)
pT2 61 (11.7) 44 (11.8) 17 (11.3)
pT3 7 (1.3) 7 (1.9) 0 (0.0)
pT4a 3 (0.6) 3 (0.8) 0 (0.0)
pT4b 5 (0.9) 2 (0.5) 3 (2.0)
Tumor size: <0.0001 *
<5 mm 89 (17.0) 66 (17.7) 24 (16.0)
5–10 mm 120 (22.7) 70 (18.7) 49 (32.6)
>10 mm 314 (60.3) 237 (63.6) 77 (51.4)
Lymph node metastasis: 0.008 *
pN0 350 (66.9) 266 (71.3) 84 (56.0)
pN1a 145 (27.7) 89 (23.9) 56 (37.3)
pN1b 6 (1.1) 3 (0.8) 3 (2.0)
pNx 22 (4.2) 15 (4.0) 7 (4.7)
Distant metastasis: <0.0001 *
pM0 450 (86.0) 337 (90.4) 113 (75.3)
pM1 19 (3.6) 15 (4.0) 4 (2.7)
pMx 54 (10.4) 21 (5.6) 33 (22.0)

* statistically significant.